Colgate-Palmolive (NYSE:CL) Given New $100.00 Price Target at Citigroup

Colgate-Palmolive (NYSE:CL) had its price objective raised by equities researchers at Citigroup from $95.00 to $100.00 in a report released on Tuesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s target price would suggest a potential upside of 15.25% from the company’s current price.

CL has been the subject of a number of other research reports. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 target price for the company. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target for the company in a research report on Monday, January 29th. Wells Fargo & Company lifted their price target on Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research report on Monday, January 29th. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. Finally, Barclays lifted their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, April 12th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $89.50.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $86.77 on Tuesday. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $90.37. The stock’s 50-day moving average is $86.97 and its 200 day moving average is $80.63. The company has a market cap of $71.32 billion, a P/E ratio of 31.21, a PEG ratio of 3.28 and a beta of 0.42. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.85 by $0.02. The business had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company’s quarterly revenue was up 6.9% on a year-over-year basis. During the same quarter last year, the company earned $0.77 earnings per share. Research analysts predict that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of the business’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the completion of the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at $686,470.05. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, EVP Gregory Malcolm sold 8,930 shares of the company’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at $686,470.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 232,371 shares of company stock worth $19,505,099. 0.37% of the stock is currently owned by insiders.

Institutional Trading of Colgate-Palmolive

Several institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Colgate-Palmolive by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 79,894,344 shares of the company’s stock worth $6,368,378,000 after buying an additional 416,853 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Colgate-Palmolive by 16.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 32,133,218 shares of the company’s stock worth $2,561,340,000 after buying an additional 4,625,472 shares in the last quarter. Geode Capital Management LLC boosted its stake in Colgate-Palmolive by 0.6% during the 1st quarter. Geode Capital Management LLC now owns 17,457,294 shares of the company’s stock valued at $1,309,583,000 after purchasing an additional 112,177 shares in the last quarter. Morgan Stanley boosted its stake in Colgate-Palmolive by 3.2% during the 3rd quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock valued at $1,195,785,000 after purchasing an additional 514,559 shares in the last quarter. Finally, Moneta Group Investment Advisors LLC boosted its stake in Colgate-Palmolive by 90,253.2% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after purchasing an additional 15,956,771 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.